Skip to main content
Clinical Trials/KCT0006605
KCT0006605
Completed
未知

A 12 weeks, randomized, double-blind, placebo-controlled human trial to evaluate the efficacy and safety of Gastrodia elata Blume extract on improvement of Cognitive Function

Wonkwang University. Iksan Korean Medicine Hospital0 sites100 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Wonkwang University. Iksan Korean Medicine Hospital
Enrollment
100
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
May 17, 2022
Last Updated
3 years ago
Study Type
Interventional Study
Sex
All

Investigators

Sponsor
Wonkwang University. Iksan Korean Medicine Hospital

Eligibility Criteria

Inclusion Criteria

  • 1\) Males and females aged 45\-65 years over at the screening examination
  • 2\) Participants who have mini mental state examination score of 20 to 28\.
  • 3\) Participants who have fully understand the information provided about the study voluntarily decided to participate and agree to comply with precautions.

Exclusion Criteria

  • 1\) The patients who have a history of alcoholism dependency/abuse within the last 3 months before the screening examination.
  • 2\) The patients who take medicine, health functional foods or oriental medicine within the last 1 month before the screening examination.
  • 3\) Patients who have participated in other clinical trials within the last 3 months before the screening examination.
  • 4\) Patients who have laboratory test outcomes as follow.
  • ? AST(Aspartate aminotransferase), ALT(Alanine Transaminase) \> three times the normal limit
  • ? Serum Creatinine \> 2\.0 mg/dL
  • 5\) Patients who are judged ineligible to participate in the trial by the principal investigator for other reasons, including laboratory test outcomes.

Outcomes

Primary Outcomes

Not specified

Similar Trials